Ratios Revealed: Decoding Caredx Inc (CDNA)’s Financial Health

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

The closing price of Caredx Inc (NASDAQ: CDNA) was $10.48 for the day, up 2.95% from the previous closing price of $10.18. In other words, the price has increased by $2.95 from its previous closing price. On the day, 0.77 million shares were traded. CDNA stock price reached its highest trading level at $10.51 during the session, while it also had its lowest trading level at $9.94.


Our analysis of CDNA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.77 and its Current Ratio is at 4.02. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.

On November 09, 2023, Stephens Upgraded its rating to Overweight which previously was Equal-Weight but kept the price unchanged to $10.

Raymond James Upgraded its Mkt Perform to Outperform on August 15, 2023, while the target price for the stock was maintained at $12.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 02 ’23 when Seeto Reginald sold 2,818 shares for $6.91 per share. The transaction valued at 19,483 led to the insider holds 479,164 shares of the business.

Seeto Reginald sold 2,819 shares of CDNA for $26,762 on Sep 05 ’23. The insider now owns 481,982 shares after completing the transaction at $9.49 per share. On Aug 14 ’23, another insider, Seeto Reginald, who serves as the insider of the company, sold 576 shares for $8.89 each. As a result, the insider received 5,123 and left with 484,801 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 545044864 and an Enterprise Value of 341441920. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.94 while its Price-to-Book (P/B) ratio in mrq is 2.07. Its current Enterprise Value per Revenue stands at 1.218 whereas that against EBITDA is -3.808.

Stock Price History:

Over the past 52 weeks, CDNA has reached a high of $12.93, while it has fallen to a 52-week low of $4.80. The 50-Day Moving Average of the stock is 8.45%, while the 200-Day Moving Average is calculated to be 15.64%.

Shares Statistics:

CDNA traded an average of 814.08K shares per day over the past three months and 857810 shares per day over the past ten days. A total of 51.50M shares are outstanding, with a floating share count of 48.91M. Insiders hold about 5.95% of the company’s shares, while institutions hold 95.54% stake in the company. Shares short for CDNA as of 1713139200 were 4692487 with a Short Ratio of 5.76, compared to 1710460800 on 4357437. Therefore, it implies a Short% of Shares Outstanding of 4692487 and a Short% of Float of 11.959999999999999.

Most Popular

[the_ad id="945"]